Effects of 2-deoxy-D-glucose on Breast Cancer Cells
Author Information
Author(s): Aft R L, Zhang F W, Gius D
Primary Institution: Washington University School of Medicine
Hypothesis
Interference with glucose metabolism by non-metabolisable glucose analogues would lead to apoptosis in breast cancer cells.
Conclusion
2-deoxy-D-glucose treatment causes death in human breast cancer cell lines by activating the apoptotic pathway.
Supporting Evidence
- 2-deoxy-D-glucose treatment resulted in cessation of cell growth in a dose-dependent manner.
- Cell viability decreased with 2-deoxy-D-glucose treatment, indicating cell death.
- Apoptosis was confirmed by increased caspase 3 activity and PARP cleavage.
- Breast cancer cells treated with 2-deoxy-D-glucose showed higher levels of Glut1 transporter protein.
Takeaway
This study found that a sugar-like drug called 2-deoxy-D-glucose can make breast cancer cells die by tricking them into thinking they are starving.
Methodology
Breast cancer cell lines were treated with varying concentrations of 2-deoxy-D-glucose, and cell growth, clonogenicity, and apoptosis were measured.
Limitations
The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.
Participant Demographics
Human breast cancer cell lines were used, including MCF-7, SkBr3, BT474, and MDA/MB468.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website